ArticleBMC geriatrics2025
Association between serum potassium and 28-day mortality in elderly patients with sepsis: a multicenter cohort study.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile dyskalemia is known to affect outcomes in critically ill patients, its specific impact on elderly septic patients remains unclear. Previous studies in general intensive care unit (ICU) populations have shown a U-shaped relationship between serum potassium and mortality, but this pattern may differ in elderly patients with sepsis.
methodsThis retrospective cohort study analyzed 12,069 patients aged ≥ 65 years with sepsis from 208 U.S. hospitals using the eICU Collaborative Research Database (2014-2015). Patients were categorized based on their admission serum potassium levels: hypokalemia (< 3.5 mmol/L), normokalemia (3.5-5.0 mmol/L), and hyperkalemia (> 5.0 mmol/L). The primary outcome was 28-day mortality.
resultsAmong the cohort (mean age 77.0 [7.6] years; 50.6% women), 16.4% had hypokalemia, 73.2% had normokalemia, and 10.4% had hyperkalemia. In contrast to the U-shaped relationship previously reported in general ICU populations, we observed a significant linear association between serum potassium and 28-day mortality (P = .001). In the unadjusted model, each 1 mmol/L increase in serum potassium was associated with 65% higher odds of mortality (OR, 1.65 [95% CI, 1.54-1.77]). This association was particularly pronounced in patients aged ≥ 80 years (OR, 1.79 [95% CI, 1.59-2.03]). After comprehensive adjustment for confounders, each 1 mmol/L increase in serum potassium was associated with 23% higher odds of mortality (adjusted OR, 1.23 [95% CI, 1.09-1.39]). Compared to normokalemia, hyperkalemia carried significantly higher mortality risk (adjusted OR, 1.45 [95% CI, 1.11-1.88]).
conclusionsOur findings challenge the established U-shaped paradigm by demonstrating a linear relationship between serum potassium and mortality in elderly septic patients. This suggests that traditional approaches to potassium management may need modification in this vulnerable population, with greater emphasis on preventing hyperkalemia. These results provide a foundation for developing age-specific potassium management strategies in sepsis care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.